GIFLF:OTCMKTS
Grifols SA Class A
11,13 USD
0,00%
(0,00) 1 D
15. sep., 15:11:14 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for GIFLF …
Markedsverdi
6,59 mrd.
Snittvolum
543,00
Volum
0,00
52 u høy
12,90 USD
52 u lav
10,13 USD
Beta
0,90
Utestående aksjer
426,13 mill.
Antall ansatte
25k
Markedsverdi
6,59 mrd.
Snittvolum
543,00
Volum
0,00
52 u høy
12,90 USD
52 u lav
10,13 USD
Beta
0,90
Utestående aksjer
426,13 mill.
Antall ansatte
25k
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 1 døgn siden
Grifols stock gains as H1 profit rises 28.7 percent
The New York Times
·
for 1 måned siden
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Om Grifols SA Class A
Administrerende direktørNacho Abia
Ansatte25k
Grunnlagt18. nov. 1940
Hovedkontor-
Sektor-
Nettstedgrifols.com